China Merchants Capital

Private Equity 1 Queen's Road East Wan Chai, Hong Kong Island, Hong Kong ·Founded 2012

Overview

China Merchants Capital (CMC) is a prominent Chinese private equity firm established in 2012, operating as a joint venture between China Merchants Group (CMG) and GLP. The firm manages assets exceeding RMB 300 billion (approximately USD 41.7 billion) across 67 funds, focusing on sectors such as transportation, infrastructure, logistics, real estate, financial services, fintech, technology, advanced manufacturing, green tech, and healthcare. CMC's investment strategies encompass early-stage, growth, late-stage, buyout, turnaround, and distressed investments, reflecting its comprehensive approach to private equity. CMC's investment philosophy emphasizes collaboration with both domestic and international investors, leveraging its extensive network to identify and capitalize on strategic opportunities. The firm's diverse portfolio includes investments in media and entertainment, consumer goods, telecommunications, energy, biotechnology, pharmaceuticals, automotive, retail, education, and more. This broad industry focus enables CMC to adapt to evolving market dynamics and pursue value creation across various sectors. With a team of over 250 investment professionals operating from offices in Beijing, Shenzhen, and Hong Kong, CMC is committed to driving innovation and growth through its investments. The firm's strategic partnership with GLP enhances its capabilities in fund management, investment operations, and global fundraising, positioning CMC as a leading player in the private equity landscape. CMC's track record includes significant investments in companies such as Juventas, a biotech firm specializing in cellular immunotherapy, and Cathay Biotech, a leader in bio-based materials, demonstrating its commitment to supporting innovative and high-growth enterprises.

Investment Focus

  • Strong management teams
  • Innovative business models
  • Scalable growth potential
  • Alignment with CMC's strategic focus areas

Portfolio Companies

JuventasCathay Biotech

Reach China Merchants Capital directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about China Merchants Capital

What sectors does China Merchants Capital invest in?

China Merchants Capital invests in Financial Services, Technology, Healthcare, Energy, Consumer Goods and Real Estate, and is based in 1 Queen's Road East Wan Chai, Hong Kong Island, Hong Kong. China Merchants Capital is listed as a private equity in the ConnectSafely investor database.

What stage does China Merchants Capital invest at?

China Merchants Capital backs companies at Early Stage, Growth, Late Stage, Buyout, Turnaround and Distressed, writing cheques of 1M - 1B.

Which regions does China Merchants Capital invest in?

China Merchants Capital invests across United States, United Kingdom, Canada, Germany, Hong Kong and Japan.

Who are the partners at China Merchants Capital?

Team members listed for China Merchants Capital include Zhaohong Ye (Vice President) and Teng (Vice President).

What companies has China Merchants Capital invested in?

China Merchants Capital's portfolio includes Juventas and Cathay Biotech.

How do I contact China Merchants Capital?

China Merchants Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database